Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 8.7% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 5,100 shares of the company’s stock after acquiring an additional 408 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Azenta were worth $256,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Thrivent Financial for Lutherans grew its position in shares of Azenta by 0.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 19,855 shares of the company’s stock worth $851,000 after buying an additional 183 shares during the period. Huntington National Bank grew its position in Azenta by 35.3% during the 2nd quarter. Huntington National Bank now owns 782 shares of the company’s stock valued at $37,000 after purchasing an additional 204 shares during the last quarter. IMA Wealth Inc. grew its position in Azenta by 0.6% during the 2nd quarter. IMA Wealth Inc. now owns 39,535 shares of the company’s stock valued at $1,845,000 after purchasing an additional 232 shares during the last quarter. Neuberger Berman Group LLC grew its position in Azenta by 1.6% during the 4th quarter. Neuberger Berman Group LLC now owns 18,356 shares of the company’s stock valued at $1,069,000 after purchasing an additional 287 shares during the last quarter. Finally, Signaturefd LLC grew its position in Azenta by 25.7% during the 2nd quarter. Signaturefd LLC now owns 1,418 shares of the company’s stock valued at $66,000 after purchasing an additional 290 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors.
Azenta Stock Performance
AZTA opened at $65.05 on Thursday. The stock has a market capitalization of $3.62 billion, a P/E ratio of -361.37 and a beta of 1.56. The company’s 50-day simple moving average is $63.62 and its two-hundred day simple moving average is $55.60. Azenta, Inc. has a 52-week low of $36.01 and a 52-week high of $69.16.
Analysts Set New Price Targets
AZTA has been the topic of several recent analyst reports. B. Riley increased their price objective on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Needham & Company LLC increased their price objective on shares of Azenta from $68.00 to $76.00 and gave the company a “buy” rating in a research report on Thursday, January 18th. Finally, Stephens reissued an “equal weight” rating and set a $55.00 price objective on shares of Azenta in a research report on Tuesday, November 14th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $70.00.
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
- Five stocks we like better than Azenta
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- What are specialty REITs? How to invest in them
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Miso Robotics stock: Is an IPO coming soon?
- What does consumer price index measure?
- Insiders are selling these hot stocks on track for higher prices
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.